The global medical membrane market size reached USD 4.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.1 Billion by 2033, exhibiting a growth rate (CAGR) of 7.15% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 4.2 Billion |
Market Forecast in 2033
|
USD 8.1 Billion |
Market Growth Rate 2025-2033 | 7.15% |
Medical membrane refers to a technology utilized in drug delivery, tissue regeneration, artificial organs, and diagnostic devices. It assists in processing products with high purity and the concentration, separation and purification of various medical processes. It also aids in the treatment of patients suffering from various pathologies by removing toxins from the blood. It is used as a selective barrier to keep immune system components from encountering implants while allowing nutrients and metabolites to permeate the cells freely. As a result, it finds applications in hospitals, ambulatory centers, clinics, and community healthcare centers around the world.
There is currently a rise in the prevalence of chronic diseases like renal failure, diabetes, and atherosclerosis across the globe. This, along with the growing utilization of medical membrane in dialysis for filtration and blood purification, represents one of the key factors driving the market. Moreover, there is an increase in the employment of medical membranes in the recovery of concentrated proteins and enzymes. This, coupled with the rising awareness among individuals about the benefits of the medical membrane, is propelling the growth of the market. In addition, the escalating demand for medical membrane devices, such as microfiltration, intravenous (IV) infusion filters and sterile filtration, for curing various diseases is offering lucrative growth opportunities to industry investors. Besides this, the growing need for artificial organ implants due to organ failure is positively influencing the market. Apart from this, rising applications of ultra-pure water for manufacturing pharmaceutical products are catalyzing the demand for medical membranes. Additionally, the escalating demand for medical membrane in wastewater treatment as it has a higher selectivity towards critical components is bolstering the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical membrane market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on technology, material and application.
Breakup by Technology:
Breakup by Material:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation), Hangzhou Cobetter Filtration Equipment Co. Ltd., Koch Separation Solutions (Koch Engineered Solutions), Medtronic plc, Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, Thermo Fisher Scientific and W. L. Gore & Associates Inc.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Technology, Material, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | 3M Company, Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation), Hangzhou Cobetter Filtration Equipment Co. Ltd., Koch Separation Solutions (Koch Engineered Solutions), Medtronic plc, Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, Thermo Fisher Scientific and W. L. Gore & Associates Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global medical membrane market was valued at USD 4.2 Billion in 2024.
We expect the global medical membrane market to exhibit a CAGR of 7.15% during 2025-2033.
The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of medical membranes as selective barriers for protecting immune system components from encountering implants, while allowing nutrients and metabolites to permeate the cells freely.
The rising prevalence of numerous chronic diseases, such as renal failures, diabetes, and atherosclerosis, along with the increasing requirement for medical membrane in dialysis procedures for filtration and blood purification, is primarily driving the global medical membrane market.
Based on the technology, the global medical membrane market can be categorized into microfiltration, ultrafiltration, nanofiltration, dialysis, gas filtration, and others. Currently, nanofiltration accounts for the majority of the global market share.
Based on the material, the global medical membrane market has been segregated into acrylics, Polypropylene (PP), Polyvinylidene Fluoride (PVDF), Polysulfone (PSU) and Polyether Sulfone (PESU), Polytetrafluoroethylene (PTFE), and others. Among these, Polysulfone (PSU) and Polyether Sulfone (PESU) currently holds the largest market share.
Based on the application, the global medical membrane market can be bifurcated into pharmaceutical filtration, IV infusion and sterile filtration, bio-artificial processes, drug delivery, hemodialysis, and others. Currently, pharmaceutical filtration exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where Europe currently dominates the global market.
Some of the major players in the global medical membrane market include 3M Company, Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation), Hangzhou Cobetter Filtration Equipment Co. Ltd., Koch Separation Solutions (Koch Engineered Solutions), Medtronic plc, Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, Thermo Fisher Scientific, and W. L. Gore & Associates Inc.